Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial

More about Open Access at the Crick

Journal details

Journal Trials
Volume 18
Issue number 1
Pages 111
Publication date


Type of publication

Crick labs/facilities